Seven in 10 Aussies admit to faking sickie in past year
Seventy per cent of Australians faked a sick day at work in the past year when they were not actually unwell, a new study has found
It was estimated sickies cost Australian businesses $7.3bn a year in lost productivity and 24.6 million days off.
The study conducted by iSelect found the most common reasons people took a sick day were a lack of sleep, to relax and recharge, mental health or personal issues to deal with family, or relationship problems.
The health insurance comparison service found when mental health issues were counted as personal leave, 68 per cent of Australians still admitted to taking a fake sick day.
The highest proportion of people pulling a sickie were workers aged 25 to 34 (84.5 per cent).
The most significant difference between men and women surveyed was that 26.6 per cent of women used a sick day for a mental health day compared with 19.5 per cent of men.
Men 12.9 (per cent) were more likely to take a sick day because they were hungover compared with women (8.5 per cent), but twice as many women (20 per cent) were more likely to take the day off to care for children than men.
Other excuses revealed some workers took sick days to attend a special event or they just wanted the day off for general leisure. Others avoided meetings or did not want to go to work because it was raining.
iSelect general manager of health Andres Gutierrez said the research found it was very common for Australians to take a sickie at least once a year despite not being physically ill.
'A lack of sleep, wanting to relax and recharge, and mental health are the top three reasons, highlighting how some Australians might choose to prioritise self-care,' he said.
'If you're finding it tough to get a good night's sleep or you're dealing with mental health challenges, it's important to reach out for support.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
9 News
10 hours ago
- 9 News
Revolutionary late-stage melanoma treatment sees survival rates surge
Your web browser is no longer supported. To improve your experience update it here A revolution in the treatment of late-stage melanoma has been reached, with clinical trial results seeing surging survival rates. Doctors are confident the new therapy approach, which will be subsidised by the Pharmaceutical Benefits Scheme (PBS), will overhaul the treatment of many types of deadly cancers. A tumour the size of a golf ball saw death come knocking for Matthew Croxford. A revolution in the treatment of late-stage melanoma has been reached with clinical trial results seeing surging survival rates (Nine) "You think - is this it?" the 52-year-old father-of-two told 9News. "And I had a lot of things to still achieve in my life." Croxford was offered to take part in an Australian and Netherlands-driven trial. The new therapy has flipped the cancer paradigm on its head, by giving the body the best opportunity to activate its own cancer-fighting defences. "It's like the sniffer dogs that find the fruit and veg and drugs at the airport, they're trained against what they need to find," The Melanoma Institute's Professor Georgina Long said. "By giving immunotherapy before surgery, we train our immune system better against the cancer," she said. A new therapy has flipped the cancer paradigm on its head by giving the body the best opportunity to activate its own cancer-fighting defences. (Nine) Of the 423 patients with Stage 3 melanoma, one group received usual treatment with surgery first, then a single immunotherapy drug. That order was then flipped for the other group, who were given two immunotherapy drugs first to shrink the tumour before surgery. "Their chance of the melanoma coming back is next to zero - it's less than five per cent," Long said. Such revolutionary results have seen the treatment approved to be funded by the PBS - a world first. Matthew Croxford was offered to take part in an Australian and Netherlands-driven trial. (Nine) Australia has the highest rates of melanoma in the world, with one person diagnosed every 30 minutes and a life lost every six hours because of the disease. Advances in treatment like this shift a diagnosis that has often been a death sentence to promising odds of survival. "I'm effectively cancer-free, I have no side effects whatsoever, and I'm incredibly fortunate," Croxford said. "It's like the sniffer dogs that find the fruit and veg and drugs at the airport, they're trained against what they need to find," The Melanoma Institute's Professor Georgina Long said. (Nine) The radical overhaul of traditional treatment is now being explored for other cancers, including lung, triple-negative breast cancer, kidney, head and neck cancers. This new treatment for Stage 3 melanoma patients is to be listed on the PBS within months. national cancer health melanoma medicine PBS CONTACT US Property News: The last inner Sydney suburbs where houses cost under $2m.
Sydney Morning Herald
10 hours ago
- Sydney Morning Herald
‘A bomb thrown into the middle of science': Trump cuts hurt Australian medical research
Australian medical research institutes are suspending projects on malaria, tuberculosis and women's health, as well as laying off staff, as they reel from the Trump administration's multibillion-dollar science cuts. The situation has drawn condemnation from Australian scientists. Burnet Institute director Professor Brendan Crabb likened the cuts to 'having a bomb thrown into the middle of science'. 'The world of science and research in all its forms … is undergoing a global seismic shift as a result of what the US is doing,' he said. 'I can't think of another circumstance since the end of World War II where things have been upended so profoundly.' Preliminary estimates from the Burnet Institute show that the US cuts have left a $1.2 million funding shortfall across the organisation's global health programs and collaborations. A spokeswoman said this had led to the suspension until 2030 of research projects involving malaria, harm reduction, tuberculosis and women's and children's health. Loading Professor James Beeson, a world-renowned malaria researcher from the Burnet Institute, said the cuts would put millions of lives at risk. Beeson pointed to research by the Malaria Atlas Project, which estimates that a complete freeze in US funding would lead to 15 million additional cases of malaria every year and 107,000 deaths. Maternal deaths, stillbirths, tuberculosis and HIV rates throughout the Asia-Pacific region and parts of Africa would also increase substantially over the next few years unless the funding cuts were reversed or replaced by other funding sources, he said.
The Age
10 hours ago
- The Age
‘A bomb thrown into the middle of science': Trump cuts hurt Australian medical research
Australian medical research institutes are suspending projects on malaria, tuberculosis and women's health, as well as laying off staff, as they reel from the Trump administration's multibillion-dollar science cuts. The situation has drawn condemnation from Australian scientists. Burnet Institute director Professor Brendan Crabb likened the cuts to 'having a bomb thrown into the middle of science'. 'The world of science and research in all its forms … is undergoing a global seismic shift as a result of what the US is doing,' he said. 'I can't think of another circumstance since the end of World War II where things have been upended so profoundly.' Preliminary estimates from the Burnet Institute show that the US cuts have left a $1.2 million funding shortfall across the organisation's global health programs and collaborations. A spokeswoman said this had led to the suspension until 2030 of research projects involving malaria, harm reduction, tuberculosis and women's and children's health. Loading Professor James Beeson, a world-renowned malaria researcher from the Burnet Institute, said the cuts would put millions of lives at risk. Beeson pointed to research by the Malaria Atlas Project, which estimates that a complete freeze in US funding would lead to 15 million additional cases of malaria every year and 107,000 deaths. Maternal deaths, stillbirths, tuberculosis and HIV rates throughout the Asia-Pacific region and parts of Africa would also increase substantially over the next few years unless the funding cuts were reversed or replaced by other funding sources, he said.
